secwatch.observer — SEC 8-K summary
======================================

Issuer:     CENTENE CORP (CNC)
CIK:        0001071739
Form:       8-K
Filed at:   2022-02-24T23:59:59+00:00
Accession:  0001071739-22-000077
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Michael Neidorff takes medical leave; James Dallas named Acting Chairman
----------------------------------------------------------------------------

- Michael Neidorff granted paid medical leave of absence as CEO, Chairman, and director effective Feb 23, 2022.
- James Dallas appointed Acting Chairman; Office of Chairman (London, Layton, Asher, Bagley) to manage daily operations.
- Board's CEO succession process ongoing, targeted for completion in Q2 2022.
- Neidorff led Centene for 26 years, growing it to Fortune 24 with over $125B revenue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1071739/000107173922000077/0001071739-22-000077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1071739/000107173922000077/cnc-20220223.htm
  HTML page:      https://secwatch.observer/filing/0001071739-22-000077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer